摘要
目的 通过对我院中成药国家基本药物使用情况进行调查分析,为促进基本药物的临床合理使用提供参考。方法 对我院2013~2015年国家基本药物的品种数、销售金额及构成比、用药频度、日均费用和科室用药分布情况进行统计分析。结果 我院中成药国家基本药物的品种数相对稳定,但是销售金额及占比呈现逐年下降的趋势;3年中各类基本药物的用药金额和DDDs排序变化较小,销售金额大的品种相对固定,说明临床对常用基本药物的选择相对集中,基本药物的用药种类和用药频度连续性较好;中成药基本药物在临床各科室的用药集中度不高,且中医科中成药的用药金额比例较低。结论 必须进一步重视和强化基本药物的合理使用,制定相关政策和措施鼓励临床积极主动地优先使用基本药物。
Abstract
OBJECTIVE To investigate and analyze the use of TCM national essential medicines in our hospital, so as to provide reference for clinical rational use. METHODS The variety number, consumption sum and constituent ratio, defined daily dose system(DDDs), defined daily cost(DDC)and drug use distribution in departments of TCM national essential medicines in our hospital were statistic analyzed during 2013-2015. RESULTS The variety number of TCM national essential medicines were relatively stable in our hospital, but the consumption sum and proportion showed a downward trend year by year. The consumption sum and DDDs of essential medicines changed less during 3 years, and the drug with large sales amount were relatively fixed, which showed that the clinical selection of essential medicines were relatively centralized, and the category and DDDs continuity of essential medicines was fairly good. The concentration ratio of TCM essential drug use were lower in clinical departments, and the consumption sum ratio were lower in TCM department.CONCLUSION We must pay more attention to the rational use of essential medicines, and formulate relevant policies and measures to encourage clinical use essential medicines preferentially.
关键词
国家基本药物 /
中成药 /
销售金额 /
用药频度 /
日均费用
{{custom_keyword}} /
Key words
National Essential Medicines /
traditional Chinese medicine patent prescription /
consumption sum /
DDDs /
DDC
{{custom_keyword}} /
张碧华, 谭玲, 梁晓丽, 谭琳, 胡欣.
我院2013~2015年中成药国家基本药物使用分析[J]. 中国药学杂志, 2017, 52(9): 797-801 https://doi.org/10.11669/cpj.2017.09.019
ZHANG Bi-hua,TAN Ling, LIANG Xiao-li, TAN Lin, HU Xin.
Utilization Analysis of TCM National Essential Medicines in Our Hospital during 2013-2015[J]. Chinese Pharmaceutical Journal, 2017, 52(9): 797-801 https://doi.org/10.11669/cpj.2017.09.019
中图分类号:
R951
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] National Health and Family Planning Commission of the People's Republic of China. National Essential Medicines(2012 edition)[S]. 2013:49-72.
[2] Ch. P(2015) Vol Ⅰ(中国药典2015年版·一部)[S]. 2015:425-1749.
[3] DONG Z J,ZHANG L Y,LI G. Analysis on utilization of Chinesepatent medicines in our hospital during 2005-2009[J]. J China Pharm(中国药房),2010,21(7):643-645.
[4] ZHANG B H, HU X, JIN P F, et al. Utilization analysis and adverse drug reaction of chinese patent medicines containing poisonous ingredientsin our hospital [J]. Chin Pharm J (中国药学杂志),2013,48(13):1126-1129.
[5] MENG R, GE J J, MA X. Re-analysis of existing problems on traditional Chinese medicine injection included in the essential drug list[J]. J China Pharm(中国药房),2010,21(36):3369-3371.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
国家卫生计生委药政司2014年度委托研究课题;国家中医药管理局全国中药特色技术传承人才培训项目(2014)
{{custom_fund}}